Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГУ «Институт неврологии, психиатрии и наркологии» Национальной академии медицинских наук Украины. 61068, Украина, Харьков, ул. Академика Павлова, 46 vfedchenko83@ukr.net
Список исп. литературыСкрыть список 1. Brites D, Fernandes A. Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation. Front Cell Neurosci 2015; 9: 476. DOI: 10.3389/fncel.2015.00476 2. Dantzer R, O’Connor JC, Freund GG et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46–56. 3. Eyre H, Baune BT. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012; 37: 1397–416. 4. Van Heesch F. Inflammation-induced depression. Studying the role of proinflammatory cytokines in anhedonia. In: Depressief door je afweersysteem. De Volkskrant, 2014; p. 18. 5. Weisse CS. Depression and immunocompetence, a review of the literature. Psych Bull 1992; 111: 475–89. 6. Kronfol Z. Immune dysregulation in major depression: a critical review of exesting evidence. Int J Neuropsychopharmacol 2002; 5: 333–43. 7. Jo WK, Zhang Y, Emrich HM, Dietrich DE. Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci 2015; 9: 268. 8. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24–31. 9. Song C, Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 760–8. 10. Xanthos DN, Sandkuhler J. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 2014; 15: 43–53. 11. Capuron L, Miller AH, Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130 (2): 226–38. DOI: 10.1016/j.pharmthera.2011.01.014 12. Capuron L, Castanon N, Role of inflammation in the development of neuropsychiatric symptom domains: evidence and mechanisms. Curr Top Behav Neurosci 2017; 31: 31–44. DOI: 10.1007/7854_2016_14 13. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732–41. 14. Sanacora G, Banasr M. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013; 73: 1172–9. 15. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62: 63–77. 16. Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry 2013; 26: 19–26. 17. Herrmann N, Swardfager W, Liu H et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–57. 18. Brydon L, Harrison NA, Walker C et al. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008; 63: 1022–9. 19. Raison CL, Borisov AS, Woolwine BJ et al. Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry 2010; 15: 535–47. 20. Eisenberger NI, Berkman ET, Inagaki TK et al. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol Psychiatry 2010; 68: 748–54. 21. Harrison NA, Brydon L, Walker C et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009; 66: 407–14. 22. Harrison NA, Brydon L, Walker C et al. Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 2009; 66: 415–22. 23. Raison CL, Rutherford RE, Woolwine BJ et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013; 70: 31–41. 24. Tyring S, Gottlieb A, Papp K et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29–35. 25. Monk JP, Phillips G, Waite R et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. J Clin Oncol 2006; 24: 1852–9. 26. Haroon E, Fleischer CC, Felger JC et al. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression. Molecular Psychiatry 2016; 21: 1351–57. 27. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016 Dec; 21 (12): 1696–709.